Patch test results with the European baseline series, 2019/20—Joint European results of the ESSCA and the EBS working groups of the ESCD, and the GEIDAC
Background Continual analyses of patch test results with the European baseline series (EBS) serve both contact allergy surveillance and auditing the value of included allergens. Objectives To present results of current EBS patch testing, obtained in 53 departments in 13 European countries during 201...
Gespeichert in:
| Veröffentlicht in: | Contact dermatitis Jg. 87; H. 4; S. 343 - 355 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Oxford, UK
Blackwell Publishing Ltd
01.10.2022
Wiley Subscription Services, Inc |
| Schlagworte: | |
| ISSN: | 0105-1873, 1600-0536, 1600-0536 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Background
Continual analyses of patch test results with the European baseline series (EBS) serve both contact allergy surveillance and auditing the value of included allergens.
Objectives
To present results of current EBS patch testing, obtained in 53 departments in 13 European countries during 2019 and 2020.
Methods
Anonymised or pseudonymised individual data and partly aggregated data on demographic/clinical characteristics and patch test rest results with the EBS were prospectively collected and centrally pooled and analysed.
Results
In 2019 and 2020, 22 581 patients were patch tested with the EBS. Sensitization to nickel remained most common (19.8 [19.2–20.4]% positivity [95% confidence interval]). Fragrance mix I and Myroxylon pereirae yielded very similar results with 6.80 (6.43–7.19)% and 6.62 (6.25–7.00)% positivity, respectively. Formaldehyde at 2% aq. yielded almost one percentage point more positive reactions than 1% concentration (2.49 [2.16–2.85]% vs. 1.59 [1.33–1.88]); methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) and MI alone up to around 5% positives. Among the new additions, propolis was most commonly positive (3.48 [3.16–3.82]%), followed by 2‐hydroxyethyl methacrylate (2.32 [2.0–2.68]%).
Conclusion
Ongoing surveillance on the prevalence of contact sensitization contributes to an up‐to‐date baseline series containing the most frequent and/or relevant contact sensitizers for routine patch testing in Europe.
Top five from 2019 to 2020: nickel 20%, fragrance mix I 7%, Myroxylon pereirae 7%, cobalt 6% and (chloro‐)methylisothiazolinone 5%. Newcomers 2019–2022: propolis 3%, with large geographic variation, 2‐hydroxyethyl methacrylate 2%. Important to test patients with the latest, updated version of the European baseline series. |
|---|---|
| AbstractList | Background
Continual analyses of patch test results with the European baseline series (EBS) serve both contact allergy surveillance and auditing the value of included allergens.
Objectives
To present results of current EBS patch testing, obtained in 53 departments in 13 European countries during 2019 and 2020.
Methods
Anonymised or pseudonymised individual data and partly aggregated data on demographic/clinical characteristics and patch test rest results with the EBS were prospectively collected and centrally pooled and analysed.
Results
In 2019 and 2020, 22 581 patients were patch tested with the EBS. Sensitization to nickel remained most common (19.8 [19.2–20.4]% positivity [95% confidence interval]). Fragrance mix I and Myroxylon pereirae yielded very similar results with 6.80 (6.43–7.19)% and 6.62 (6.25–7.00)% positivity, respectively. Formaldehyde at 2% aq. yielded almost one percentage point more positive reactions than 1% concentration (2.49 [2.16–2.85]% vs. 1.59 [1.33–1.88]); methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) and MI alone up to around 5% positives. Among the new additions, propolis was most commonly positive (3.48 [3.16–3.82]%), followed by 2‐hydroxyethyl methacrylate (2.32 [2.0–2.68]%).
Conclusion
Ongoing surveillance on the prevalence of contact sensitization contributes to an up‐to‐date baseline series containing the most frequent and/or relevant contact sensitizers for routine patch testing in Europe.
Top five from 2019 to 2020: nickel 20%, fragrance mix I 7%, Myroxylon pereirae 7%, cobalt 6% and (chloro‐)methylisothiazolinone 5%. Newcomers 2019–2022: propolis 3%, with large geographic variation, 2‐hydroxyethyl methacrylate 2%. Important to test patients with the latest, updated version of the European baseline series. BackgroundContinual analyses of patch test results with the European baseline series (EBS) serve both contact allergy surveillance and auditing the value of included allergens.ObjectivesTo present results of current EBS patch testing, obtained in 53 departments in 13 European countries during 2019 and 2020.MethodsAnonymised or pseudonymised individual data and partly aggregated data on demographic/clinical characteristics and patch test rest results with the EBS were prospectively collected and centrally pooled and analysed.ResultsIn 2019 and 2020, 22 581 patients were patch tested with the EBS. Sensitization to nickel remained most common (19.8 [19.2–20.4]% positivity [95% confidence interval]). Fragrance mix I and Myroxylon pereirae yielded very similar results with 6.80 (6.43–7.19)% and 6.62 (6.25–7.00)% positivity, respectively. Formaldehyde at 2% aq. yielded almost one percentage point more positive reactions than 1% concentration (2.49 [2.16–2.85]% vs. 1.59 [1.33–1.88]); methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) and MI alone up to around 5% positives. Among the new additions, propolis was most commonly positive (3.48 [3.16–3.82]%), followed by 2‐hydroxyethyl methacrylate (2.32 [2.0–2.68]%).ConclusionOngoing surveillance on the prevalence of contact sensitization contributes to an up‐to‐date baseline series containing the most frequent and/or relevant contact sensitizers for routine patch testing in Europe. Continual analyses of patch test results with the European baseline series (EBS) serve both contact allergy surveillance and auditing the value of included allergens.BACKGROUNDContinual analyses of patch test results with the European baseline series (EBS) serve both contact allergy surveillance and auditing the value of included allergens.To present results of current EBS patch testing, obtained in 53 departments in 13 European countries during 2019 and 2020.OBJECTIVESTo present results of current EBS patch testing, obtained in 53 departments in 13 European countries during 2019 and 2020.Anonymised or pseudonymised individual data and partly aggregated data on demographic/clinical characteristics and patch test rest results with the EBS were prospectively collected and centrally pooled and analysed.METHODSAnonymised or pseudonymised individual data and partly aggregated data on demographic/clinical characteristics and patch test rest results with the EBS were prospectively collected and centrally pooled and analysed.In 2019 and 2020, 22 581 patients were patch tested with the EBS. Sensitization to nickel remained most common (19.8 [19.2-20.4]% positivity [95% confidence interval]). Fragrance mix I and Myroxylon pereirae yielded very similar results with 6.80 (6.43-7.19)% and 6.62 (6.25-7.00)% positivity, respectively. Formaldehyde at 2% aq. yielded almost one percentage point more positive reactions than 1% concentration (2.49 [2.16-2.85]% vs. 1.59 [1.33-1.88]); methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) and MI alone up to around 5% positives. Among the new additions, propolis was most commonly positive (3.48 [3.16-3.82]%), followed by 2-hydroxyethyl methacrylate (2.32 [2.0-2.68]%).RESULTSIn 2019 and 2020, 22 581 patients were patch tested with the EBS. Sensitization to nickel remained most common (19.8 [19.2-20.4]% positivity [95% confidence interval]). Fragrance mix I and Myroxylon pereirae yielded very similar results with 6.80 (6.43-7.19)% and 6.62 (6.25-7.00)% positivity, respectively. Formaldehyde at 2% aq. yielded almost one percentage point more positive reactions than 1% concentration (2.49 [2.16-2.85]% vs. 1.59 [1.33-1.88]); methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) and MI alone up to around 5% positives. Among the new additions, propolis was most commonly positive (3.48 [3.16-3.82]%), followed by 2-hydroxyethyl methacrylate (2.32 [2.0-2.68]%).Ongoing surveillance on the prevalence of contact sensitization contributes to an up-to-date baseline series containing the most frequent and/or relevant contact sensitizers for routine patch testing in Europe.CONCLUSIONOngoing surveillance on the prevalence of contact sensitization contributes to an up-to-date baseline series containing the most frequent and/or relevant contact sensitizers for routine patch testing in Europe. |
| Author | Giménez‐Arnau, Ana Pesonen, Maria Werfel, Thomas Filon, Francesca Larese Borrego, Leopoldo Dugonik, Aleksandra Gonçalo, Margarida Patruno, Cataldo Schubert, Steffen Aerts, Olivier Buhl, Timo Schuttelaar, Marie‐L. A. Uter, Wolfgang Garcìa, Pedro Mercader Weisshaar, Elke Valiukevičienė, Skaidra Dickel, Heinrich Stingeni, Luca Brans, Richard Bauer, Andrea Simon, Dagmar Rustemeyer, Thomas Wilkinson, S. Mark Pónyai, Györgyi |
| Author_xml | – sequence: 1 givenname: Wolfgang orcidid: 0000-0002-4498-3710 surname: Uter fullname: Uter, Wolfgang email: wolfgang.uter@fau.de organization: Friedrich‐Alexander‐Universität Erlangen‐Nürnberg – sequence: 2 givenname: S. Mark orcidid: 0000-0001-7253-3461 surname: Wilkinson fullname: Wilkinson, S. Mark organization: Leeds Teaching Hospitals NHS Trust – sequence: 3 givenname: Olivier orcidid: 0000-0002-0076-2887 surname: Aerts fullname: Aerts, Olivier organization: University Hospital Antwerp (UZA) and Research group Immunology, Infla‐Med Centre of Excellence, University of Antwerp – sequence: 4 givenname: Andrea orcidid: 0000-0002-4411-3088 surname: Bauer fullname: Bauer, Andrea organization: University Hospital Carl Gustav Carus, Technical University – sequence: 5 givenname: Leopoldo orcidid: 0000-0002-0199-2756 surname: Borrego fullname: Borrego, Leopoldo organization: Complejo Hospitalario Universitario Insular Materno Infantil, Universidad de las Palmas de Gran Canaria – sequence: 6 givenname: Richard orcidid: 0000-0002-1245-024X surname: Brans fullname: Brans, Richard organization: Institute for Interdisciplinary Dermatologic Prevention and Rehabilitation (iDerm) at the University of Osnabrück – sequence: 7 givenname: Timo orcidid: 0000-0002-3139-129X surname: Buhl fullname: Buhl, Timo organization: University Medical Center Göttingen, Göttingen – sequence: 8 givenname: Heinrich orcidid: 0000-0001-6837-4402 surname: Dickel fullname: Dickel, Heinrich organization: St. Josef Hospital, University Medical Center, Ruhr University Bochum – sequence: 9 givenname: Aleksandra orcidid: 0000-0001-8433-7716 surname: Dugonik fullname: Dugonik, Aleksandra organization: University Medical Centre Maribor – sequence: 10 givenname: Francesca Larese orcidid: 0000-0002-7717-0417 surname: Filon fullname: Filon, Francesca Larese organization: University of Trieste – sequence: 11 givenname: Pedro Mercader orcidid: 0000-0002-8309-9725 surname: Garcìa fullname: Garcìa, Pedro Mercader organization: Hospital Morales Meseguer – sequence: 12 givenname: Ana orcidid: 0000-0002-3898-0652 surname: Giménez‐Arnau fullname: Giménez‐Arnau, Ana organization: Hospital del Mar, Institut Mar d´Investigacions Mèdiques, Universitat Pompeu Fabra de Barcelona – sequence: 13 givenname: Cataldo orcidid: 0000-0001-8661-2822 surname: Patruno fullname: Patruno, Cataldo organization: University Magna Graecia of Catanzaro – sequence: 14 givenname: Maria orcidid: 0000-0003-0356-7064 surname: Pesonen fullname: Pesonen, Maria organization: Finnish Institute of Occupational Health – sequence: 15 givenname: Györgyi orcidid: 0000-0002-1695-6133 surname: Pónyai fullname: Pónyai, Györgyi organization: Semmelweis University – sequence: 16 givenname: Thomas orcidid: 0000-0001-7580-0684 surname: Rustemeyer fullname: Rustemeyer, Thomas organization: Amsterdam University Medical Centers – sequence: 17 givenname: Steffen orcidid: 0000-0002-2359-2518 surname: Schubert fullname: Schubert, Steffen organization: Institute at the University Medical Centre Göttingen – sequence: 18 givenname: Marie‐L. A. orcidid: 0000-0002-0766-4382 surname: Schuttelaar fullname: Schuttelaar, Marie‐L. A. organization: University Medical Center Groningen, University of Groningen – sequence: 19 givenname: Dagmar orcidid: 0000-0001-8965-9407 surname: Simon fullname: Simon, Dagmar organization: Inselspital, Bern University Hospital, University of Bern – sequence: 20 givenname: Luca orcidid: 0000-0001-7919-8141 surname: Stingeni fullname: Stingeni, Luca organization: University of Perugia – sequence: 21 givenname: Skaidra orcidid: 0000-0003-1219-5928 surname: Valiukevičienė fullname: Valiukevičienė, Skaidra organization: Lithuanian University of Health Sciences – sequence: 22 givenname: Elke orcidid: 0000-0002-7016-0224 surname: Weisshaar fullname: Weisshaar, Elke organization: University Hospital Heidelberg – sequence: 23 givenname: Thomas orcidid: 0000-0001-6830-7672 surname: Werfel fullname: Werfel, Thomas organization: Hannover Medical School – sequence: 24 givenname: Margarida orcidid: 0000-0001-6842-1360 surname: Gonçalo fullname: Gonçalo, Margarida organization: University Hospital and Faculty of Medicine, University of Coimbra |
| BookMark | eNp1kc1u1DAUhS1UJKaFBW9giQ1ITcc_sRMvh8xQiioVaWBtOclN65Lag-1o1F0fghWPx5NgSPlRBd7Y1_rO0dU5h-jAeQcIPafkhOaz7Hx_QktakUdoQSUhBRFcHqAFoUQUtK74E3QY4zUhVJasXqCv703qrnCCmHCAOI0p4r1N-ecK8GYKfgfG4dZEGK0DHCFYiMeYEaqWjHy7-_LOW5f-kL88_DA7bLfNChvXz9PrLd778Mm6S3wZ_LT7i2vWx7-5083ZetU8RY8HM0Z4dn8foY9vNh-at8X5xelZszovOi4FKSirxMCHthSSqqplquxAKQ5SCq5oLzqpWkFaDqxmyvC6F7QfeK9AQCeq_DxCL2ffXfCfpxyEvrGxg3E0DvwUNZNVWQlBJc_oiwfotZ-Cy9tpVtEcKmOiztRyprrgYwww6M4mk6x3KRg7akr0j6507kr_7CorXj1Q7IK9MeH2n-y9-96OcPt_UDcX61nxHe9soyE |
| CitedBy_id | crossref_primary_10_1111_cod_14493 crossref_primary_10_1016_j_jaip_2024_04_060 crossref_primary_10_1111_cod_14430 crossref_primary_10_1016_j_envint_2025_109605 crossref_primary_10_3390_toxics12110802 crossref_primary_10_1016_j_ad_2024_03_024 crossref_primary_10_1016_j_ad_2024_10_063 crossref_primary_10_1089_derm_2023_0139 crossref_primary_10_1007_s00403_025_04286_9 crossref_primary_10_1016_j_ad_2024_05_018 crossref_primary_10_1016_j_freeradbiomed_2025_02_005 crossref_primary_10_2478_amb_2023_0027 crossref_primary_10_1111_cod_70031 crossref_primary_10_1111_cod_14524 crossref_primary_10_1111_cod_14523 crossref_primary_10_1111_cod_14820 crossref_primary_10_1111_cod_14405 crossref_primary_10_1111_cod_14724 crossref_primary_10_1111_cod_14525 crossref_primary_10_1111_cod_14520 crossref_primary_10_1111_cod_14641 crossref_primary_10_1016_j_ad_2024_02_006 crossref_primary_10_1111_cod_14423 crossref_primary_10_1007_s00403_024_03101_1 crossref_primary_10_1111_cod_14488 crossref_primary_10_1111_cod_14362 crossref_primary_10_2340_actadv_v104_41079 crossref_primary_10_1016_j_ecoenv_2024_117631 crossref_primary_10_1111_cod_14683 crossref_primary_10_1089_derm_2023_0140 crossref_primary_10_3390_life15050698 crossref_primary_10_1089_derm_2023_0186 crossref_primary_10_7759_cureus_66944 crossref_primary_10_1016_j_ad_2023_10_039 crossref_primary_10_1111_cod_14737 crossref_primary_10_1111_cod_14419 crossref_primary_10_1111_cod_70021 crossref_primary_10_1111_cod_14678 crossref_primary_10_1111_cod_14316 crossref_primary_10_1055_a_2331_4038 crossref_primary_10_1111_cod_14454 crossref_primary_10_1111_cod_14255 crossref_primary_10_1111_cod_14698 crossref_primary_10_1111_cod_14059 crossref_primary_10_1111_cod_14730 |
| Cites_doi | 10.1111/cod.13941 10.1111/j.1365‐2133.2011.10781.x 10.1111/cod.13181 10.1002/pds.4064 10.1111/j.1600-0536.1999.tb06154.x 10.1111/cod.12651 10.1111/jdv.14423 10.1111/j.0105-1873.2003.0225n.x 10.1111/j.1600‐0536.2010.01865.x 10.1111/cod.13660 10.1111/cod.13450 10.1111/cod.12112 10.1111/cod.12874 10.1111/cod.12941 10.1016/j.ad.2020.06.003 10.1097/DER.0b013e31824a63c6 10.1111/cod.13778 10.1111/cod.12795 10.1111/cod.12400 10.1111/cod.13704 10.1111/all.15149 10.1111/j.1600‐0536.1992.tb00865.x 10.1111/cod.12871 10.1111/cod.13786 10.1111/cod.12736 10.1111/jdv.15505 10.1111/cod.13917 10.3414/ME15-01-0099 10.1111/cod.13956 10.1034/j.1600‐0536.2003.480210.x 10.3390/ijerph17072404 10.1111/cod.12352 10.1111/cod.13836 10.1111/bjd.18946 10.1097/DER.0000000000000137 10.1111/all.14460 10.1111/cod.12824 10.1111/cod.12240 10.1097/ACI.0000000000000373 10.1111/cod.12822 10.1111/j.1525‐1470.2011.01533.x 10.1111/j.1600-0536.2012.02064.x 10.1111/j.0105‐1873.2005.00529.x 10.1111/cod.13155 10.1111/cod.13960 10.1111/cod.13322 10.1111/cod.14059 10.2340/actadv.v101.423 10.1111/j.1600-0536.1997.tb02435.x 10.1016/j.adengl.2021.07.013 10.1111/j.1600-0536.2011.01964.x 10.1111/cod.13691 10.1111/j.1600‐0536.2009.01547.x 10.1111/ddg.13099 10.1111/cod.12432 10.1111/cod.13717 10.1111/cod.13326 |
| ContentType | Journal Article |
| Copyright | 2022 The Authors. published by John Wiley & Sons Ltd. 2022. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd. |
| Copyright_xml | – notice: 2022 The Authors. published by John Wiley & Sons Ltd. – notice: 2022. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd. |
| CorporateAuthor | for the ESSCA and EBS ESCD working groups, and the GEIDAC |
| CorporateAuthor_xml | – name: for the ESSCA and EBS ESCD working groups, and the GEIDAC |
| DBID | 24P AAYXX CITATION 7T5 H94 7X8 |
| DOI | 10.1111/cod.14170 |
| DatabaseName | Wiley Online Library Open Access CrossRef Immunology Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef AIDS and Cancer Research Abstracts Immunology Abstracts MEDLINE - Academic |
| DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1600-0536 |
| EndPage | 355 |
| ExternalDocumentID | 10_1111_cod_14170 COD14170 |
| Genre | article |
| GrantInformation_xml | – fundername: Fundación Piel Sana Academia Española de Dermatología y Venereología – fundername: Agencia Española de Medicamentos y Productos Sanitarios – fundername: EADV |
| GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1CY 1OB 1OC 24P 29F 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAKAS AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABHFT ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFEBI AFFNX AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHEFC AIACR AIAGR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 CYRXZ D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LMP LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WVDHM WXI WXSBR X7M XG1 YOC YUY ZGI ZXP ZZTAW ~IA ~WT AAYXX AIQQE CITATION O8X 7T5 H94 7X8 |
| ID | FETCH-LOGICAL-c3650-1275f3fb456197b294ce993e665391d5c69b50b3e2829a38d51df3d9e5ec57df3 |
| IEDL.DBID | 24P |
| ISICitedReferencesCount | 63 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000815350500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0105-1873 1600-0536 |
| IngestDate | Fri Jul 11 09:06:11 EDT 2025 Fri Jul 25 19:22:48 EDT 2025 Tue Nov 18 22:14:58 EST 2025 Sat Nov 29 05:45:28 EST 2025 Sun Jul 06 04:45:04 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| License | Attribution-NonCommercial |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3650-1275f3fb456197b294ce993e665391d5c69b50b3e2829a38d51df3d9e5ec57df3 |
| Notes | Funding information Agencia Española de Medicamentos y Productos Sanitarios; EADV; Fundación Piel Sana Academia Española de Dermatología y Venereología Members of the ESSCA and EBS Working Groups, and GEIDAC are provided in Appendix section. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-0076-2887 0000-0001-8433-7716 0000-0002-3139-129X 0000-0002-0766-4382 0000-0002-0199-2756 0000-0001-7919-8141 0000-0002-1245-024X 0000-0001-6837-4402 0000-0002-3898-0652 0000-0003-0356-7064 0000-0002-7717-0417 0000-0001-8965-9407 0000-0001-6842-1360 0000-0002-8309-9725 0000-0003-1219-5928 0000-0001-7253-3461 0000-0002-1695-6133 0000-0002-4411-3088 0000-0002-2359-2518 0000-0002-4498-3710 0000-0001-8661-2822 0000-0001-7580-0684 0000-0002-7016-0224 0000-0001-6830-7672 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcod.14170 |
| PQID | 2710012258 |
| PQPubID | 105341 |
| PageCount | 13 |
| ParticipantIDs | proquest_miscellaneous_2674755163 proquest_journals_2710012258 crossref_citationtrail_10_1111_cod_14170 crossref_primary_10_1111_cod_14170 wiley_primary_10_1111_cod_14170_COD14170 |
| PublicationCentury | 2000 |
| PublicationDate | October 2022 2022-10-00 20221001 |
| PublicationDateYYYYMMDD | 2022-10-01 |
| PublicationDate_xml | – month: 10 year: 2022 text: October 2022 |
| PublicationDecade | 2020 |
| PublicationPlace | Oxford, UK |
| PublicationPlace_xml | – name: Oxford, UK – name: Malden |
| PublicationTitle | Contact dermatitis |
| PublicationYear | 2022 |
| Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc |
| References | 2013; 69 2012; 166 2014; 90 2021; 101 2015; 73 2019; 33 2015; 72 2020; 83 2009; 60 2020; 82 2020; 183 2000; 42 2020; 17 2016; 75 1999; 41 2022; 86 2016; 180 2016; 14 2016; 55 2019; 80 2017; 31 2015; 26 2019; 81 2020; 75 2021; 112 2017; 17 2020 1997; 37 2017; 77 2017; 76 2011; 64 2005; 52 2020; 379 2003; 48 2003; 49 2011; 65 2020; 111 2012; 29 1992; 26 2022; 77 2018; 78 2021; 85 2012; 67 2012; 23 2021; 84 2014; 71 2016; 25 e_1_2_10_23_1 e_1_2_10_46_1 e_1_2_10_21_1 e_1_2_10_44_1 e_1_2_10_40_1 Isaksson M (e_1_2_10_58_1) 2000; 42 e_1_2_10_2_1 e_1_2_10_4_1 e_1_2_10_18_1 e_1_2_10_53_1 e_1_2_10_6_1 e_1_2_10_16_1 e_1_2_10_39_1 e_1_2_10_55_1 e_1_2_10_8_1 e_1_2_10_14_1 e_1_2_10_37_1 e_1_2_10_57_1 e_1_2_10_13_1 e_1_2_10_34_1 e_1_2_10_32_1 e_1_2_10_30_1 e_1_2_10_51_1 (e_1_2_10_42_1) 2016; 180 e_1_2_10_61_1 e_1_2_10_29_1 e_1_2_10_63_1 e_1_2_10_27_1 e_1_2_10_48_1 e_1_2_10_24_1 e_1_2_10_45_1 e_1_2_10_22_1 e_1_2_10_43_1 e_1_2_10_20_1 e_1_2_10_41_1 e_1_2_10_52_1 e_1_2_10_3_1 e_1_2_10_19_1 e_1_2_10_54_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_38_1 e_1_2_10_7_1 e_1_2_10_15_1 e_1_2_10_36_1 Uter W (e_1_2_10_9_1) 2020 e_1_2_10_12_1 e_1_2_10_35_1 e_1_2_10_59_1 e_1_2_10_10_1 e_1_2_10_33_1 e_1_2_10_31_1 (e_1_2_10_25_1) 2014; 90 e_1_2_10_50_1 Uter W (e_1_2_10_11_1) 2020 (e_1_2_10_56_1) 2020; 379 e_1_2_10_60_1 e_1_2_10_62_1 e_1_2_10_64_1 e_1_2_10_28_1 e_1_2_10_49_1 e_1_2_10_26_1 e_1_2_10_47_1 |
| References_xml | – volume: 26 start-page: 230 issue: 5 year: 2015 end-page: 234 article-title: Multicenter patch testing with a resol resin based on phenol and formaldehyde within the international contact dermatitis research group publication-title: Dermatitis – volume: 101 issue: 11 year: 2021 article-title: Patch testing with propolis of different geographical origins in a baseline series publication-title: Acta Derm Venereol – volume: 33 start-page: e242 issue: 6 year: 2019 end-page: e244 article-title: Clinicians vs. epidemiologists: patch testing with methyldibromo glutaronitrile as a controversial issue publication-title: J Eur Acad Dermatol Venereol – volume: 17 issue: 7 year: 2020 article-title: Contact allergy‐emerging allergens and public health impact publication-title: Int J Environ Res Public Health – volume: 67 start-page: 36 issue: 1 year: 2012 end-page: 41 article-title: Contact sensitization to tree moss ( extract, INCI) is heterogeneous publication-title: Contact Dermatitis – volume: 65 start-page: 322 issue: 6 year: 2011 end-page: 328 article-title: The ‘overall yield’ with the baseline series—a useful addition to the array of MOAHLFA factors describing departmental characteristics of patch tested patients publication-title: Contact Dermatitis – volume: 85 start-page: 523 issue: 5 year: 2021 end-page: 530 article-title: Chromium and cobalt release from metallic earrings from the Danish market publication-title: Contact Dermatitis – volume: 41 start-page: 241 issue: 5 year: 1999 end-page: 250 article-title: Thoughts on sensitizers in a standard patch test series. The European Society of Contact Dermatitis publication-title: Contact Dermatitis – volume: 29 start-page: 540 issue: 4 year: 2012 end-page: 541 article-title: Bra‐associated allergic contact dermatitis: ‐ ‐butylphenol formaldehyde resin as the culprit publication-title: Pediatr Dermatol – volume: 64 start-page: 289 issue: 5 year: 2011 end-page: 291 article-title: Nickel allergy in Spain needs active intervention publication-title: Contact Dermatitis – volume: 37 start-page: 200 issue: 5 year: 1997 end-page: 209 article-title: National rates and regional differences in sensitization to allergens of the standard series. Population‐adjusted frequencies of sensitization (PAFS) in 40,000 patients from a multicenter study (IVDK) publication-title: Contact Dermatitis – volume: 77 start-page: 270 issue: 5 year: 2017 end-page: 279 article-title: Non‐mix fragrances are top sensitizers in consecutive dermatitis patients—a cross‐sectional study of the 26 EU‐labelled fragrance allergens publication-title: Contact Dermatitis – volume: 86 start-page: 379 issue: 5 year: 2022 end-page: 389 article-title: European patch test results with audit allergens as candidates for inclusion in the European baseline series, 2019/20: joint results of the ESSCA and the EBS working groups of the ESCD, and the GEIDAC publication-title: Contact Dermatitis – volume: 48 start-page: 108 issue: 2 year: 2003 end-page: 111 article-title: Contact dermatitis from electrocardiograph‐monitoring electrodes: role of ‐ ‐butylphenol‐formaldehyde resin publication-title: Contact Dermatitis – volume: 69 start-page: 350 issue: 6 year: 2013 end-page: 354 article-title: What can be learnt from nothing? A statistical perspective publication-title: Contact Dermatitis – volume: 81 start-page: 280 issue: 4 year: 2019 end-page: 287 article-title: New positive patch test reactions on day 7‐the additional value of the day 7 patch test reading publication-title: Contact Dermatitis – volume: 73 start-page: 15 issue: 1 year: 2015 end-page: 20 article-title: Recommendation to include a textile dye mix in the European baseline series publication-title: Contact Dermatitis – volume: 111 start-page: 650 issue: 8 year: 2020 end-page: 654 article-title: Patch testing during the COVID‐19 pandemic: recommendations of the AEDV's Spanish contact dermatitis and skin allergy research group (GEIDAC) publication-title: Actas Dermosifiliogr – volume: 180 start-page: 15 year: 2016 end-page: 17 article-title: Commission implementing regulation (EU) 2016/1086 of July 5, 2016 approving 2‐bromo‐2‐(bromomethyl)pentanedinitrile (DBDCB) as an existing active substance for use in biocidal products of product‐type 6 (text with EEA relevance) publication-title: Official J Eur Union – volume: 26 start-page: 34 issue: 1 year: 1992 end-page: 44 article-title: Propolis allergy (IV). Studies with further sensitizers from propolis and constituents common to propolis, poplar buds and balsam of Peru publication-title: Contact Dermatitis – volume: 90 start-page: 1 year: 2014 end-page: 3 article-title: Anonymous. Commission regulation (EU) no 301/2014 of march 25, 2014 amending annex XVII to regulation (EC) no 1907/2006 of the European Parliament and of the council on the registration, evaluation, authorisation and restriction of chemicals (REACH) as regards chromium VI compounds publication-title: Official J Eur Union – volume: 77 start-page: 1477 issue: 5 year: 2022 end-page: 1485 article-title: The benefit of late readings in patch testing depends both on allergen and patient characteristics publication-title: Allergy – volume: 77 start-page: 328 issue: 5 year: 2017 end-page: 330 article-title: Linear eczema on the amputation stump as a clinical clue to the diagnosis publication-title: Contact Dermatitis – volume: 17 start-page: 263 issue: 4 year: 2017 end-page: 268 article-title: Allergic contact dermatitis in preservatives: current standing and future options publication-title: Curr Opin Allergy Clin Immunol – volume: 55 start-page: 193 issue: 2 year: 2016 end-page: 199 article-title: Registries in clinical epidemiology: the European Surveillance System on Contact Allergies (ESSCA) publication-title: Methods Inf Med – start-page: 1 year: 2020 end-page: 4 – volume: 82 start-page: 247 issue: 4 year: 2020 end-page: 250 article-title: Sensitization to nickel in the Triveneto region: temporal trend after European Union regulations publication-title: Contact Dermatitis – volume: 166 start-page: 761 issue: 4 year: 2012 end-page: 770 article-title: Concentration variability of potent allergens of ‐ ‐butylphenol‐formaldehyde resin (PTBP‐FR) in patch test preparations and commercially available PTBP‐FR publication-title: Br J Dermatol – volume: 84 start-page: 109 issue: 2 year: 2021 end-page: 120 article-title: Patch test results with the European baseline series and additions thereof in the ESSCA network, 2015‐2018 publication-title: Contact Dermatitis – volume: 23 start-page: 125 issue: 3 year: 2012 end-page: 126 article-title: Allergic contact dermatitis to p‐tert butylphenol formaldehyde resin in a continuous positive airway pressure strap publication-title: Dermatitis – volume: 73 start-page: 195 issue: 4 year: 2015 end-page: 221 article-title: European Society of Contact Dermatitis guideline for diagnostic patch testing recommendations on best practice publication-title: Contact Dermatitis – volume: 75 start-page: 2997 issue: 11 year: 2020 end-page: 2999 article-title: Is time to remove parabens from standard patch test batteries? Retrospective study of 10 461 patients publication-title: Allergy – volume: 52 start-page: 197 issue: 4 year: 2005 end-page: 206 article-title: Quantitative patch and repeated open application testing in methyldibromo glutaronitrile‐sensitive patients publication-title: Contact Dermatitis – volume: 83 start-page: 387 issue: 5 year: 2020 end-page: 390 article-title: Patch testing with a textile dye mix with and without Disperse Orange 3 publication-title: Contact Dermatitis – volume: 85 start-page: 611 issue: 5 year: 2021 end-page: 613 article-title: Arguments in favour of excluding MDBGN from the European baseline series. In response to "comment on MDBGN/DBDCB, the European baseline series, and EU legislation" publication-title: Contact Dermatitis – volume: 49 start-page: 270 issue: 5 year: 2003 end-page: 271 article-title: A multilingual European patch test software concept: WinAlldat/ESSCA publication-title: Contact Dermatitis – volume: 112 start-page: 798 issue: 9 year: 2021 end-page: 805 article-title: Candidate allergens for inclusion in the Spanish standard series based on data from the Spanish contact dermatitis registry publication-title: Actas Dermosifiliogr – volume: 31 start-page: 1516 issue: 9 year: 2017 end-page: 1525 article-title: European Surveillance System on Contact Allergies (ESSCA): results with the European baseline series, 2013/14 publication-title: J Eur Acad Dermatol Venereol – volume: 183 start-page: 857 issue: 5 year: 2020 end-page: 865 article-title: Trends and current spectrum of contact allergy in Central Europe: results of the information network of departments of dermatology (IVDK) 2007‐2018 publication-title: Br J Dermatol – volume: 71 start-page: 35 issue: 1 year: 2014 end-page: 40 article-title: Recommendation to increase the test concentration of methylchloroisothiazolinone/methylisothiazolinone in the European baseline patch test series ‐ on behalf of the European Society of Contact Dermatitis and the European Environmental and Contact Dermatitis Research Group publication-title: Contact Dermatitis – volume: 80 start-page: 1 issue: 1 year: 2019 end-page: 4 article-title: The European baseline series and recommended additions: 2019 publication-title: Contact Dermatitis – start-page: 1 year: 2020 end-page: 16 – volume: 77 start-page: 163 issue: 3 year: 2017 end-page: 170 article-title: Airborne allergic contact dermatitis caused by isothiazolinones in water‐based paints: a retrospective study of 44 cases publication-title: Contact Dermatitis – volume: 81 start-page: 242 issue: 4 year: 2019 end-page: 248 article-title: Causative exposures and temporal development of cobalt allergy in Denmark between 2002 and 2017 publication-title: Contact Dermatitis – volume: 379 start-page: 31 year: 2020 end-page: 33 article-title: COMMISSION REGULATION (EU) 2020/1682 of November 12, 2020 amending Annex III to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products publication-title: Official J Eur Union – volume: 72 start-page: 256 issue: 4 year: 2015 end-page: 258 article-title: Fragrance mix I: TRUE Test® versus pet.‐based patch test publication-title: Contact Dermatitis – volume: 85 start-page: 643 issue: 6 year: 2021 end-page: 649 article-title: Evolution of methylisothiazolinone sensitization: a Belgian multicentric study from 2014 to 2019 publication-title: Contact Dermatitis – volume: 78 start-page: 321 issue: 5 year: 2018 end-page: 328 article-title: Nickel and cobalt release from earrings and piercing jewellery—analytical results of a German survey in 2014 publication-title: Contact Dermatitis – volume: 85 start-page: 722 issue: 6 year: 2021 end-page: 724 article-title: Contact sensitization to propolis in the information network of departments of dermatology (IVDK) 2013 to 2019 and market survey of propolis commerce in Germany publication-title: Contact Dermatitis – volume: 85 start-page: 125 year: 2021 end-page: 128 article-title: The European baseline series: criteria for allergen inclusion (with reference to formaldehyde releasers) publication-title: Contact Dermatitis – volume: 84 start-page: 254 issue: 4 year: 2021 end-page: 262 article-title: The epidemic of contact allergy to methylisothiazolinone‐an analysis of Danish consecutive patients patch tested between 2005 and 2019 publication-title: Contact Dermatitis – volume: 84 start-page: 95 issue: 2 year: 2021 end-page: 102 article-title: Formaldehyde 2% is not a useful means of detecting allergy to formaldehyde releasers‐ results of the ESSCA network, 2015‐2018 publication-title: Contact Dermatitis – volume: 42 start-page: 352 issue: 6 year: 2000 end-page: 354 article-title: Patch testing with budesonide in serial dilutions. A multicentre study of the EECDRG publication-title: Contact Dermatitis – volume: 25 start-page: 1305 issue: 11 year: 2016 end-page: 1312 article-title: Contact allergy to ingredients of topical medications: results of the European Surveillance System on Contact Allergies (ESSCA), 2009‐2012 publication-title: Pharmacoepidemiol Drug Saf – volume: 80 start-page: 156 issue: 3 year: 2019 end-page: 161 article-title: Temporal changes in chromium allergy in Denmark between 2002 and 2017 publication-title: Contact Dermatitis – volume: 14 start-page: 707 issue: 7 year: 2016 end-page: 715 article-title: Survey of sensitizing components of oxidative hair dyes (retail and professional products) in Germany publication-title: J Dtsch Dermatol Ges – volume: 78 start-page: 76 issue: 1 year: 2018 end-page: 82 article-title: Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study publication-title: Contact Dermatitis – volume: 78 start-page: 159 issue: 2 year: 2018 end-page: 161 article-title: Comparing patch test results of methylchloroisothiazolinone/methylisothiazolinone tested with both TRUE test and 100 ppm using investigator‐loaded chambers publication-title: Contact Dermatitis – volume: 84 start-page: 419 issue: 6 year: 2021 end-page: 422 article-title: Decrease of contact allergy to hydroxyisohexyl 3‐cyclohexene carboxaldehyde in Europe prior to its ban and diagnostic value publication-title: Contact Dermatitis – volume: 76 start-page: 195 issue: 4 year: 2017 end-page: 203 article-title: Patch testing with rubber series in Europe: a critical review and recommendation publication-title: Contact Dermatitis – volume: 75 start-page: 345 issue: 6 year: 2016 end-page: 352 article-title: Patch test results with rubber series in the European Surveillance System on Contact Allergies (ESSCA), 2013/14 publication-title: Contact Dermatitis – volume: 60 start-page: 314 issue: 6 year: 2009 end-page: 319 article-title: ‐Phenylenediamine sensitization is more prevalent in central and southern European patch test centres than in Scandinavian: results from a multicentre study publication-title: Contact Dermatitis – ident: e_1_2_10_41_1 doi: 10.1111/cod.13941 – ident: e_1_2_10_49_1 doi: 10.1111/j.1365‐2133.2011.10781.x – ident: e_1_2_10_26_1 doi: 10.1111/cod.13181 – ident: e_1_2_10_60_1 doi: 10.1002/pds.4064 – ident: e_1_2_10_2_1 doi: 10.1111/j.1600-0536.1999.tb06154.x – ident: e_1_2_10_47_1 doi: 10.1111/cod.12651 – volume: 42 start-page: 352 issue: 6 year: 2000 ident: e_1_2_10_58_1 article-title: Patch testing with budesonide in serial dilutions. A multicentre study of the EECDRG publication-title: Contact Dermatitis – ident: e_1_2_10_8_1 doi: 10.1111/jdv.14423 – ident: e_1_2_10_14_1 doi: 10.1111/j.0105-1873.2003.0225n.x – ident: e_1_2_10_17_1 doi: 10.1111/j.1600‐0536.2010.01865.x – ident: e_1_2_10_62_1 doi: 10.1111/cod.13660 – ident: e_1_2_10_18_1 doi: 10.1111/cod.13450 – ident: e_1_2_10_15_1 doi: 10.1111/cod.12112 – ident: e_1_2_10_59_1 doi: 10.1111/cod.12874 – ident: e_1_2_10_28_1 doi: 10.1111/cod.12941 – ident: e_1_2_10_19_1 doi: 10.1016/j.ad.2020.06.003 – ident: e_1_2_10_51_1 doi: 10.1097/DER.0b013e31824a63c6 – ident: e_1_2_10_57_1 doi: 10.1111/cod.13778 – ident: e_1_2_10_37_1 doi: 10.1111/cod.12795 – ident: e_1_2_10_61_1 doi: 10.1111/cod.12400 – ident: e_1_2_10_7_1 doi: 10.1111/cod.13704 – ident: e_1_2_10_21_1 doi: 10.1111/all.15149 – volume: 180 start-page: 15 year: 2016 ident: e_1_2_10_42_1 article-title: Commission implementing regulation (EU) 2016/1086 of July 5, 2016 approving 2‐bromo‐2‐(bromomethyl)pentanedinitrile (DBDCB) as an existing active substance for use in biocidal products of product‐type 6 (text with EEA relevance) publication-title: Official J Eur Union – start-page: 1 volume-title: Contact Dermatitis year: 2020 ident: e_1_2_10_9_1 – ident: e_1_2_10_32_1 doi: 10.1111/j.1600‐0536.1992.tb00865.x – ident: e_1_2_10_23_1 doi: 10.1111/cod.12871 – volume: 90 start-page: 1 year: 2014 ident: e_1_2_10_25_1 article-title: Anonymous. Commission regulation (EU) no 301/2014 of march 25, 2014 amending annex XVII to regulation (EC) no 1907/2006 of the European Parliament and of the council on the registration, evaluation, authorisation and restriction of chemicals (REACH) as regards chromium VI compounds publication-title: Official J Eur Union – ident: e_1_2_10_30_1 doi: 10.1111/cod.13786 – ident: e_1_2_10_46_1 doi: 10.1111/cod.12736 – ident: e_1_2_10_39_1 doi: 10.1111/jdv.15505 – ident: e_1_2_10_29_1 doi: 10.1111/cod.13917 – volume: 379 start-page: 31 year: 2020 ident: e_1_2_10_56_1 article-title: COMMISSION REGULATION (EU) 2020/1682 of November 12, 2020 amending Annex III to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products publication-title: Official J Eur Union – ident: e_1_2_10_12_1 doi: 10.3414/ME15-01-0099 – ident: e_1_2_10_35_1 doi: 10.1111/cod.13956 – ident: e_1_2_10_53_1 doi: 10.1034/j.1600‐0536.2003.480210.x – ident: e_1_2_10_55_1 doi: 10.3390/ijerph17072404 – ident: e_1_2_10_22_1 doi: 10.1111/cod.12352 – ident: e_1_2_10_3_1 doi: 10.1111/cod.13836 – ident: e_1_2_10_24_1 doi: 10.1111/bjd.18946 – ident: e_1_2_10_54_1 doi: 10.1097/DER.0000000000000137 – ident: e_1_2_10_45_1 doi: 10.1111/all.14460 – ident: e_1_2_10_50_1 doi: 10.1111/cod.12824 – ident: e_1_2_10_38_1 doi: 10.1111/cod.12240 – ident: e_1_2_10_43_1 doi: 10.1097/ACI.0000000000000373 – start-page: 1 volume-title: Contact Dermatitis year: 2020 ident: e_1_2_10_11_1 – ident: e_1_2_10_31_1 doi: 10.1111/cod.12822 – ident: e_1_2_10_52_1 doi: 10.1111/j.1525‐1470.2011.01533.x – ident: e_1_2_10_48_1 doi: 10.1111/j.1600-0536.2012.02064.x – ident: e_1_2_10_40_1 doi: 10.1111/j.0105‐1873.2005.00529.x – ident: e_1_2_10_4_1 doi: 10.1111/cod.13155 – ident: e_1_2_10_33_1 doi: 10.1111/cod.13960 – ident: e_1_2_10_20_1 doi: 10.1111/cod.13322 – ident: e_1_2_10_6_1 doi: 10.1111/cod.14059 – ident: e_1_2_10_34_1 doi: 10.2340/actadv.v101.423 – ident: e_1_2_10_13_1 doi: 10.1111/j.1600-0536.1997.tb02435.x – ident: e_1_2_10_5_1 doi: 10.1016/j.adengl.2021.07.013 – ident: e_1_2_10_16_1 doi: 10.1111/j.1600-0536.2011.01964.x – ident: e_1_2_10_44_1 doi: 10.1111/cod.13691 – ident: e_1_2_10_63_1 doi: 10.1111/j.1600‐0536.2009.01547.x – ident: e_1_2_10_64_1 doi: 10.1111/ddg.13099 – ident: e_1_2_10_10_1 doi: 10.1111/cod.12432 – ident: e_1_2_10_36_1 doi: 10.1111/cod.13717 – ident: e_1_2_10_27_1 doi: 10.1111/cod.13326 |
| SSID | ssj0016428 |
| Score | 2.566771 |
| Snippet | Background
Continual analyses of patch test results with the European baseline series (EBS) serve both contact allergy surveillance and auditing the value of... BackgroundContinual analyses of patch test results with the European baseline series (EBS) serve both contact allergy surveillance and auditing the value of... Continual analyses of patch test results with the European baseline series (EBS) serve both contact allergy surveillance and auditing the value of included... |
| SourceID | proquest crossref wiley |
| SourceType | Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 343 |
| SubjectTerms | Allergens baseline series clinical epidemiology contact allergy Nickel patch testing RRID:SCR_001905 Surveillance |
| Title | Patch test results with the European baseline series, 2019/20—Joint European results of the ESSCA and the EBS working groups of the ESCD, and the GEIDAC |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcod.14170 https://www.proquest.com/docview/2710012258 https://www.proquest.com/docview/2674755163 |
| Volume | 87 |
| WOSCitedRecordID | wos000815350500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1600-0536 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0016428 issn: 0105-1873 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5VLUJcWp5iaakM4sChEes4iWNxWrJdHiplxVJpb5HtOKJSla2aLFz5EZz4efwSZpxHFwkkJC6RrUxiy-MZz8P-DPBMcSstug0Bl6UOotJEgU6swaqW3CkVJsaj65_I09N0uVTzLXjZn4Vp8SGGgBtJhtfXJODa1BtCblG_8IhL9Nd3OBcp3dsQRvMhhUCGtd-_SFCbqRQdrBBt4xk-_X0xurYwN-1Uv9DM9v6ri7dht7Mv2aSdEHdgy1V34eb7LoN-D37MUfd-ZmhgNgw97fVFUzOKxTI0BFkfmme0tlHzjCaoq48YLuDqRTj--e37u9V51VxT9v9Yle0fFotswnRVtLVXC_a1jcYzf3xkgy6bHg10r4_fTifZfTibHX_K3gTd_QyBFWjYBYQNXwpkL9pgSppQRRa5K1xCcLe8iG2iTDw2wlG2Vou0iHlRikK52NlYYvEBbFeryj0EVqjQlkgy1txFcSwM4eIn3IlQRyYRegTPe0bltgMvpzs0LvLeicGxzv1Yj-DpQHrZInb8ieig53beCW2dh4R0xFHBpSN4MrxGcaMciq7cao00CfpflFwU2CXP-783kmcfpr7w6N9J9-FWSAcs_HbBA9hurtbuMdywX5rz-urQz3B8ymV6CDvTj7Ozk191l_24 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB4hQC0X-hZLoTWIAweiruM81hKXJcuWx7KgLkjcIsdxBBLKIjYL1_6Invrz-CWdcR4sEpUq9WYrE9vyzNjzsD8DbEmuQ41ug8PDTDlelniOCnSCVRVyI6UbJBZdfxAOh53LS3k2B7v1XZgSH6IJuJFm2PWaFJwC0jNarnGB4R4P0WFf8FCMUL4Xej_6F4Mmi0C2tT3CSGibnVBUyEJ0kqf5-fl-9GRkzpqqdq_pv_m_Ub6F5crGZN1SKN7BnMnfw6uTKov-AX6f4fp7xdDILBh629ObYsIoHsvQGGR1eJ7R_kb9MxJSM9lhuInLb2778eevo_F1XjxR1m2Ms7KF0SjqMpWnZW1vxB7KiDyzV0hm6KLeTkP3ff-w140-wkV__zw6cKo3Ghwt0LhzCB8-E8hitMNkmLjS08hhYQKCvOWprwOZ-O1EGMrYKtFJfZ5mIpXGN9oPsfgJ5vNxblaApdLVGZK0FTee74uEsPEDboSrvCQQqgXbNadiXQGY0zsaN3HtyOBcx3auW7DZkN6WqB0vEa3V7I4rxZ3ELqEdcVzkOi3YaD6jylEeReVmPEWaAH0wSjAKHJJl_t87iaPTni2s_jvpV3h9cH4yiAeHw-PPsOTShQt7fHAN5ou7qVmHRX1fXE_uvlQC_wdg7wDF |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB6hBaFeWqCtui0UF3HgQNR1nMda4rJN2BZYtiu2SNwix3FUJJRFbLa99kf0xM_rL-mM82CRWqlSb7YysS2PZzwP-zPAvuQ61Og2ODzMlePlqeeoQKdYVSE3UrpBatH1R-F43L-6kpMVOGruwlT4EG3AjSTD6msScHOb5UtSrlHBcI-H6LCvevSITAdW44vh5ajNIpBtbY8wEtpmPxQ1shCd5Gl_frwfPRiZy6aq3WuGz_5vlBvwtLYx2aBaFJuwYootWD-vs-jP4X6C-vcrQyOzZOhtL27KOaN4LENjkDXheUb7G_XPaJGa-SHDTVy-d3u_fvw8nV0X5QNl08Ysr1qYTqMBU0VW1T5M2fcqIs_sFZIluig-bOk-Hp_Eg-gFXA6Pv0SfnPqNBkcLNO4cwofPBbIY7TAZpq70NHJYmIAgb3nm60Cmfi8VhjK2SvQzn2e5yKTxjfZDLL6ETjErzCtgmXR1jiQ9xY3n-yIlbPyAG-EqLw2E6sJBw6lE1wDm9I7GTdI4MjjXiZ3rLuy1pLcVasefiLYbdie14M4Tl9COOCq5fhfetZ9R5CiPogozWyBNgD4YJRgFDsky_--dJNHn2BZe_zvpLqxP4mEyOhmfvYEnLt23sKcHt6FT3i3MDqzpb-X1_O5tvd5_A-lWAEA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Patch+test+results+with+the+European+baseline+series%2C+2019%2F20%E2%80%94Joint+European+results+of+the+ESSCA+and+the+EBS+working+groups+of+the+ESCD%2C+and+the+GEIDAC&rft.jtitle=Contact+dermatitis&rft.au=Uter%2C+Wolfgang&rft.au=Wilkinson%2C+S+Mark&rft.au=Aerts%2C+Olivier&rft.au=Bauer%2C+Andrea&rft.date=2022-10-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0105-1873&rft.eissn=1600-0536&rft.volume=87&rft.issue=4&rft.spage=343&rft.epage=355&rft_id=info:doi/10.1111%2Fcod.14170&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0105-1873&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0105-1873&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0105-1873&client=summon |